Glucose Induces β-Cell Apoptosis Via Upregulation of the Fas Receptor in Human Islets
- Kathrin Maedler1,
- Giatgen A. Spinas1,
- Roger Lehmann1,
- Pavel Sergeev1,
- Markus Weber2,
- Adriano Fontana3,
- Nurit Kaiser4 and
- Marc Y. Donath1
- 1Division of Endocrinology and Diabetes, the
- 2Department of Surgery, and the
- 3Division of Clinical Immunology, University Hospital, Zurich, Switzerland
- 4Department of Endocrinology and Metabolism, Hebrew University-Hadassah Medical Center, Jerusalem, Israel
Abstract
In autoimmune type 1 diabetes, Fas–to–Fas-ligand (FasL) interaction may represent one of the essential pro-apoptotic pathways leading to a loss of pancreatic β-cells. In the advanced stages of type 2 diabetes, a decline in β-cell mass is also observed, but its mechanism is not known. Human islets normally express FasL but not the Fas receptor. We observed upregulation of Fas in β-cells of type 2 diabetic patients relative to nondiabetic control subjects. In vitro exposure of islets from nondiabetic organ donors to high glucose levels induced Fas expression, caspase-8 and -3 activation, and β-cell apoptosis. The effect of glucose was blocked by an antagonistic anti-Fas antibody, indicating that glucose-induced apoptosis is due to interaction between the constitutively expressed FasL and the upregulated Fas. These results support a new role for glucose in regulating Fas expression in human β-cells. Upregulation of the Fas receptor by elevated glucose levels may contribute to β-cell destruction by the constitutively expressed FasL independent of an autoimmune reaction, thus providing a link between type 1 and type 2 diabetes.
Footnotes
-
Address correspondence and reprint requests to Marc Y. Donath MD, Division of Endocrinology and Diabetes, Department of Medicine, University Hospital, CH-8091 Zurich, Switzerland. E-mail: marc.donath{at}dim.usz.ch.
Received for publication 28 March 2001 and accepted in revised form 15 May 2001. Posted on the World Wide Web at www.diabetes.org/diabetes on 21 June 2001.
DTT, dithiothreitol; FasL, Fas-ligand; PBS, phosphate-buffered saline; TUNEL, terminal deoxynucleotidyl transferase-mediated dUTP nick-end labeling.














